Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Entegris Inc (ENTG) vs Procter & Gamble Co (PG) Price & Performance

Entegris IncTrade
Procter & Gamble CoTrade

Price performance (Past 24H)

Key statistics

Entegris Inc vs Procter & Gamble Co — how do they compare? Entegris Inc trades at $150.21 (market cap $23.24B), while Procter & Gamble Co trades at $145.25 (market cap $340.39B). The key difference: Procter & Gamble Co is far larger — about 14.6× Entegris Inc's market cap, and Procter & Gamble Co pays the higher dividend (2.97%). Which is the better fit depends on your goals.

ENTGPG
Market Cap
$23.24B$340.39B
Sector
TechnologyConsumer Staples
52-Week High
$184.00$167.18
52-Week Low
$68.80$138.10
Enterprise Value
$26.44B$366.23B
Dividend Yield
0.26%2.97%
Volume
6,423,436

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Entegris Inc

ENTG is trading at $152.08, up 6.61% over 24 hours, near its consensus price target of $181.17. The stock shows bullish momentum with strong earnings beats in recent quarters, driven by AI-related semiconductor demand. Technical indicators suggest a bullish trend, though RSI hints at overbought conditions. Revenue growth and margin expansion are supported by increasing chip complexity and purity solutions demand.

Outlook remains positive with analyst consensus favoring Buy (66.67%), but high valuation multiples like P/E of 76.04 pose risks. Key opportunities include sustained AI-driven growth, while risks involve valuation sensitivity and semiconductor cycle volatility. The company's cash flow stability and strategic positioning in advanced segments support long-term potential.

Procter & Gamble Co

Procter & Gamble (PG) trades at $146.38, up 0.42% today, with a bearish technical signal but strong fundamentals. The stock has consistently beaten earnings estimates in recent quarters, with Q3 2026 EPS expected at $1.90. Revenue reached $84.28B in 2025, with a net income margin of 18.44% and robust cash flow from operations of $17.82B. Analyst consensus is bullish with a $161.20 price target, though valuation multiples like P/E of 22.12 and P/S of 4.08 are at premiums to peers.

The outlook for PG is positive due to steady earnings growth and dividend reliability, but risks include premium valuation concerns and soft demand headwinds. Investors may find opportunity in its defensive qualities amid market volatility, though near-term upside could be limited by technical resistance and modest revenue growth projections.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Entegris Inc

Entegris Inc is a supplier of advanced materials and process solutions for the semiconductor and other high-technology industries. The company's reportable segments include Specialty Chemicals & Engineered Materials (SCEM), Microcontamination Control (MC), and Advanced Materials Handling (AMH). The SCEM segment provides high-performance & high-purity process chemistries, gases, & materials, and safe & efficient delivery systems. The Microcontamination Control (MC) segment includes solutions to purify critical liquid chemistries and process gases used in semiconductor manufacturing processes and other high-technology industries. Its geographical segments are Taiwan, North America, South Korea, Japan, China, Europe, and Southeast Asia.

Read more on ENTG

About Procter & Gamble Co

The Procter & Gamble Company manufactures and markets consumer products in countries throughout the world. The Company provides products in the laundry and cleaning, paper, beauty care, food and beverage, and health care segments. Procter & Gamble products are sold primarily through mass merchandisers, grocery stores, membership club stores, drug stores, and neighborhood stores.

Read more on PG